There has been a recent call for global malaria eradication. The prospects of achieving this
ambitious goal are diminished by the limited tool set now available—notably, the lack of a …

The global research community must take up the challenge to work toward the eradication of
malaria. In the past, malaria research has focused on drugs and vaccines that target the …

Plasmodium vivax continues to cause significant morbidity outside Africa with more than
50% of malaria cases in many parts of South and South-east Asia, Pacific islands, Central …

Despite decades of research and multiple initiatives, malaria continues to be one of the
world's most debilitating infectious diseases. New insights for malaria control and vaccine …

Malaria control relies heavily on the use of anti-malarial drugs and insecticides against
malaria parasites and mosquito vectors. Drug and insecticide resistance threatens the …

A live-attenuated malaria vaccine, Plasmodium falciparum sporozoite vaccine (PfSPZ
Vaccine), confers sterile protection against controlled human malaria infection (CHMI) with …

Malaria is a life‐threatening disease caused by parasites of the P lasmodium genus. In
many parts of the world, the parasites have developed resistance to a number of antimalarial …

Background Previous research indicates that a combination vaccine targeting different
stages of the malaria life cycle is likely to provide the most effective malaria vaccine. This …

More attention is being focused on malaria today than any time since the world's last efforts
to achieve eradication over 40 years ago. The global community is now discussing …

Malaria, caused by the protozoan Plasmodium, is a devastating disease with over 200
million new cases reported globally every year. Although immunization is arguably the best …